Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease

NCT05611372 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No suitable recruitment

Conditions

REM Sleep Behavior Disorder
Parkinson Disease
Synucleinopathies

Interventions

DRUG: Rasagiline

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]